HomepageBCCOY • OTCMKTS
add
Bico Group
Vorige slotkoers
$ 0,90
Jaar-range
$ 0,71 - $ 1,55
Beurswaarde
2,07 mld. SEK
Gem. volume
207,00
Marktnieuws
.INX
1,83%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(SEK) | sep 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 495,50 mln. | -15,67% |
Bedrijfskosten | 312,80 mln. | -7,57% |
Netto inkomsten | -246,20 mln. | -252,22% |
Netto winstmarge | -49,69 | -317,56% |
Winst per aandeel | — | — |
EBITDA | 36,90 mln. | -60,79% |
Effectief belastingtarief | -5,77% | — |
Balans
Totale activa
Totale passiva
(SEK) | sep 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 649,80 mln. | 15,62% |
Totale activa | 5,47 mld. | -38,24% |
Totale passiva | 2,70 mld. | -7,93% |
Totaal aandelenvermogen | 2,77 mld. | — |
Uitstaande aandelen | 70,57 mln. | — |
Koers-boekwaardeverhouding | 0,02 | — |
Rendement op activa | -2,22% | — |
Rendement op kapitaal | -2,58% | — |
Kasstroom
Nettomutatie in liquide middelen
(SEK) | sep 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -246,20 mln. | -252,22% |
Operationele kasstroom | 45,00 mln. | 1.150,00% |
Kasstroom uit beleggingen | -27,30 mln. | 73,08% |
Kasstroom uit financiering | -18,30 mln. | 36,90% |
Nettomutatie in liquide middelen | -5,30 mln. | 95,88% |
Vrije kasstroom | -269,76 mln. | -250,45% |
Over
Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Opgericht
27 jan 2016
Website
Werknemers
824